Exact P-Values and Their Interpretation

  • Ton J. Cleophas
  • Aeilko H. Zwinderman


In marketing and business research the 5 % cut-off p-value has been largely abandoned, and replaced with exact p-values used as criterion for making decisions on the risk men are willing to take.


Area Under Curve Prior Expectation Common Misunderstanding Statistical Table Multiple Endpoint 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    SAS Statistical Software (2013) 2 Sept 2013
  2. 2.
    SPSS Statistical Software (2013) 2 Sept 2013
  3. 3.
    S-plus Statistical Software (2013) 2 Sept 2013
  4. 4.
    Stata Statistical Software (2013) 2 Sept 2013
  5. 5.
    P Value Calculator (2013) 30 June 2013
  6. 6.
    Z Score to P Value Calculator (2013)>Statistics. 30 June 2013Google Scholar
  7. 7.
    Free p-Value Calculation for an F-test (2013)>StatisticsCalculators. 30 June 2013Google Scholar
  8. 8.
    Levin RI, Rubin DS (1998) P-value. In: Levin RI, Rubin DS (eds) Statistics for management. Prentice-Hall, Upper Saddle River, NJ, USA, pp 485–496Google Scholar
  9. 9.
    Utts JM (1999) P-value. In: Utts JM (ed) Seeing through statistics. Duxbury Press, Detroit, pp 375–386Google Scholar
  10. 10.
    Cleophas TJ, Zwinderman AH, Cleophas AF (2004) P-values. Review. Am J Ther 11:317–322PubMedCrossRefGoogle Scholar
  11. 11.
    Cleophas TJ, Zwinderman AH, Cleophas AF (2004) P-values, beware of the extremes. Clin Chem Lab Med 42:300–305PubMedCrossRefGoogle Scholar
  12. 12.
    Michelson S, Schofield T (1996) P-values as conditional probabilities. In: Michelson S, Schofield T (eds) The biostatistics cookbook. Kluwer Academic Publishers, Boston, pp 46–58Google Scholar
  13. 13.
    Petrie A, Sabin C (2000) Explanation of p-values. In: Petrie A, Sabin C (eds) Medical statistics at glance. Blackwell Science, Oxford, pp 42–45Google Scholar
  14. 14.
    Matthews DE, Farewel VT (1996) P-value. In: Matthews DE, Farewell VT (eds) Using and understanding medical statistics. Karger, New York, pp 15–18Google Scholar
  15. 15.
    Riffenburgh RH (1999) P-values. In: Riffenburgh RH (ed) Statistics in medicine. Academic Press, San Diego, pp 95–96, 105–106Google Scholar
  16. 16.
    Cleophas TJ, Cleophas GM (2001) Sponsored research and continuing medical education. JAMA 286:302–304PubMedGoogle Scholar
  17. 17.
    Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al, for the HOT Study Group (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755–1762Google Scholar
  18. 18.
    Sandham JD, Hull RD, Brand RF, Knox L, Pineo GF, Doig CJ et al, for the Canadian Critical Care Clinical Trials Group (2003) A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348:5–14Google Scholar
  19. 19.
    LIPID Study Group (2002) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 359:1379–1387CrossRefGoogle Scholar
  20. 20.
    Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22CrossRefGoogle Scholar
  21. 21.
    Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 326:10–16PubMedCrossRefGoogle Scholar
  22. 22.
    Seppälä H, Nissinen A, Järvinen H, Huovinen S, Henrikson T, Herva E et al (1992) Resistance to erythromycin in group A streptococci. N Engl J Med 326:292–297PubMedCrossRefGoogle Scholar
  23. 23.
    Rafal ES, Griffiths CE, Ditre CM, Finkel LJ, Hamilton TA, Ellis CN et al (1992) Topical retinoin treatment for liver spots associated with photodamage. N Engl J Med 326:368–374PubMedCrossRefGoogle Scholar
  24. 24.
    Barrett BJ, Parfrey PS, Vavasour HM, O’Dea F, Kent G, Stone E (1992) A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 326:431–436PubMedCrossRefGoogle Scholar
  25. 25.
    Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. Br Med J 2:769–782CrossRefGoogle Scholar
  26. 26.
    Motulsky H (1995) P-values, definition and common misinterpretations. In: Motulsky H (ed) Intuitive biostatistics. Oxford University Press, New York, pp 96–97Google Scholar

Copyright information

© Springer Science + Business Media Dordrecht 2013

Authors and Affiliations

  • Ton J. Cleophas
    • 1
  • Aeilko H. Zwinderman
    • 2
  1. 1.Department MedicineAlbert Schweitzer HospitalSliedrechtThe Netherlands
  2. 2.Department Biostatistics and EpidemiologyAcademic Medical CenterAmsterdamThe Netherlands

Personalised recommendations